MEDTRONIC VASCULAR GALWAY UNLIMITED COMPANY
Location
Founded
1989-12-19
Website
Risk Signals
4962 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Surgical and Medical Instruments and Apparatus, Drugs, Drug Proprietaries, and Druggists' Sundries), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about MEDTRONIC VASCULAR GALWAY UNLIMITED COMPANY
Live alerts from global media, monitored by Business Radar
2025-04-24 (openpr.com)
Deep Brain Stimulation Systems Market to Witness Impressive Growth by 2032: Abbott, Medtronic, Brainlab, Nexstim
Press release - HTF Market Intelligence Consulting Pvt. Ltd. - Deep Brain Stimulation Systems Market to Witness Impressive Growth by 2032: Abbott, Medtronic, Brainlab, Nexstim - published on openPR.com
Read more
2025-04-22 (medpagetoday.com)
Isturisa's New Indication; Wegovy Pill Submitted to FDA; Type 5 Diabetes? | MedPage Today
The FDA expanded the approval of osilodrostat (Isturisa) to include treatment of endogenous hypercortisolemia in adults with Cushing's syndromeopens in a new tab or window for whom surgery is not an option or was not curative, said maker Recordati.
Read more
2025-04-18 (globenewswire.com)
Smart Hospital Market Forecast Report and Company Analysis 2025-2033 Featuring Koninklijke Philips, Medtronic, SAP, Cerner Corp, and Schneider Electric Healthcare
Growth in adoption of smart hospitals is increasing through heightened demand for effective healthcare, growth in chronic diseases, and improvement in...
Read more
2025-04-15 (mddionline.com)
Wearable Neuro Device Approved to Assist Rehab of Stroke & SCI Wearable Neuro Device Approved to Assist Rehab of Stroke & SCI
Neuvotion is set to launch its first product, a non-invasive digital neuromodulation technology that focuses on regaining hand function for patients.
Read more
2025-04-15 (beckersspine.com)
Spine robots won't remain a 'one-trick pony' - Becker's Spine Review
Spine robots are going to become more versatile with expanded applications, spine surgeon Peter Miller, MD, PhD, predicts. Dr. Miller, of Iredell Memorial Hospital in Statesville, N.C., completed his 100th case using Medtronic's Mazor robot on April 1. He spoke with Becker's about his experience with spine robots and what's next for the technology. Note: […]
Read more
2025-04-14 (telanganatoday.com)
KIMS Group partners with Medtronic to upskill 100 young surgeons across multiple specialties-
Nearly 100 young surgeons are set to receive advanced training to strengthen their skills in specialties including General Surgery, Oncology, Urology-Gynaecology, and Endoscopy. The comprehensive upskilling programs will combine classroom instruction, practical hands-on training, and observership opportunities, offering a well-rounded learning experience tailored to each surgeon's area of focus.
Read more
2025-04-07 (mddionline.com)
Medtronic's MiniMed 780G Leads in Time in Target Range for Type 1 Diabetes Medtronic's MiniMed 780G Leads in Time in Target Range for Type 1 Diabetes
A new meta-analysis ranks the efficacy of hybrid closed-loop systems for managing type 1 diabetes, finding that Medtronic's MiniMed 780G performed best for time in the target range.
Read more
2025-03-24 (medicalmanager.ro)
Prof. dr. Iulian Velea: SmartGuard reduces the burden of daily decisions related to insulin adjustment -
Prof. dr. Iulian Velea explained the importance of SmartGuard technology, used by the insulin pump Minimed 780g, in improving the glycemic control of…
Read more
2025-03-11 (pharmiweb.com)
Global Defibrillator Market Set to Exceed US$ 16.3 Billion by 2035, Driven by Technological Advancements and Rising Cardiac Arrest Cases -
The global defibrillator market was valued at US$ 7.2 billion in 2021 and is estimated to expand at a compound annual growth rate (CAGR) of 8.9% from 2022 to 2031. The market is projected to surpass US$ 16.3 billion by the end of 2031, driven by advancements in medical technology, increasing prevalence of...
Read more
2024-12-09 (modernhealthcare.com)
Medtronic: Best in Business 2024 |
OVERVIEW: Medtronic, in collaboration with Clue Digital, executed a successful campaign for its MiniMed 780G, tailored to engage Canada's Type 1 Diabetes community. Through first-party data and sophisticated audience analytics, the campaign identified key community segments and delivered tailored messaging across multiple digital channels. This personalized approach ensured resonance, relevance and high engagement, making Medtronic a leader in precision healthcare marketing.
Read more
2024-04-11 (nasdaq.com)
Medtronic's (MDT) Sphere-360 PFA Study Outcome Favorable |
Medtronic plc MDT recently presented positive clinical trial safety and efficacy results for Sphere-360 -- an investigational single-shot mapping and ablation catheter using pulsed field (PF) energy The catheter is intended for tr
Read more
2024-01-11 (marketresearchfuture.com)
Pacemaker Devices Market Research Report By Type (Single Chamber Pacemakers, Dual Chamber Pacemakers, Biventricular Pacemakers), By Technology (Permanent Pacemakers, Temporary Pacemakers, MRI-Conditional Pacemakers), By End Use (Hospitals, Ambulatory Surgical Centers, Cardiac Clinics), By Component (Pulse Generator, Lead Wires, Battery) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa)-Forecast to 2035
Pacemaker Devices Market Industry is expected to grow from 4.92(USD Billion) in 2024 to 8.2 (USD Billion) by 2035. The Pacemaker Devices Market CAGR (growth rate) is expected to be around 4.75% during the forecast period (2025 - 2035).
Read more